Global Flunixin Meglumine API Market Growth 2025-2031

Product Code: 1584956

Industry: Chemical & Material

Published: May 22,2025

Pages: 120

Delivery Time: 2-3 business days

Global Flunixin Meglumine API Market Growth 2025-2031

Product Code: 1584956

Industry: Chemical & Material

Published: May 22,2025

Pages: 120

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Flunixin Meglumine API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Flunixin Meglumine is an organic compound with the molecular formula C14H11F3N2O2.C7H17NO5, which can relieve inflammation and pain caused by abnormal muscles
United States market for Flunixin Meglumine API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Flunixin Meglumine API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Flunixin Meglumine API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Flunixin Meglumine API players cover Rochem International Inc, Ashland, Excella GmbH, Cayman Chemical, NGL Fine-Chem Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Flunixin Meglumine API Industry Forecast” looks at past sales and reviews total world Flunixin Meglumine API sales in 2024, providing a comprehensive analysis by region and market sector of projected Flunixin Meglumine API sales for 2025 through 2031. With Flunixin Meglumine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flunixin Meglumine API industry.

This Insight Report provides a comprehensive analysis of the global Flunixin Meglumine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flunixin Meglumine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Flunixin Meglumine API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flunixin Meglumine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flunixin Meglumine API.

This report presents a comprehensive overview, market shares, and growth opportunities of Flunixin Meglumine API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Solid
    Liquid

Segmentation by Application:
    Horse
    Pig
    Cattle
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Rochem International Inc
    Ashland
    Excella GmbH
    Cayman Chemical
    NGL Fine-Chem Ltd
    Chemwill Asia Co., Ltd.
    Zhejiang Hisoar Pharmaceutical
    Shandong Lukang Pharmaceutical Co., Ltd.
    Hubei Longxiang Pharmaceutical Technology Co., Ltd.
    Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd.
    Shanghai Maclean Biochemical Technology Co., Ltd.
    Hangzhou Dayangchem
    Qilu Synva Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Flunixin Meglumine API market?
What factors are driving Flunixin Meglumine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flunixin Meglumine API market opportunities vary by end market size?
How does Flunixin Meglumine API break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Flunixin Meglumine API Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Flunixin Meglumine API by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Flunixin Meglumine API by Country/Region, 2020, 2024 & 2031
    2.2 Flunixin Meglumine API Segment by Type
        2.2.1 Solid
        2.2.2 Liquid
    2.3 Flunixin Meglumine API Sales by Type
        2.3.1 Global Flunixin Meglumine API Sales Market Share by Type (2020-2025)
        2.3.2 Global Flunixin Meglumine API Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Flunixin Meglumine API Sale Price by Type (2020-2025)
    2.4 Flunixin Meglumine API Segment by Application
        2.4.1 Horse
        2.4.2 Pig
        2.4.3 Cattle
        2.4.4 Others
    2.5 Flunixin Meglumine API Sales by Application
        2.5.1 Global Flunixin Meglumine API Sale Market Share by Application (2020-2025)
        2.5.2 Global Flunixin Meglumine API Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Flunixin Meglumine API Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Flunixin Meglumine API Breakdown Data by Company
        3.1.1 Global Flunixin Meglumine API Annual Sales by Company (2020-2025)
        3.1.2 Global Flunixin Meglumine API Sales Market Share by Company (2020-2025)
    3.2 Global Flunixin Meglumine API Annual Revenue by Company (2020-2025)
        3.2.1 Global Flunixin Meglumine API Revenue by Company (2020-2025)
        3.2.2 Global Flunixin Meglumine API Revenue Market Share by Company (2020-2025)
    3.3 Global Flunixin Meglumine API Sale Price by Company
    3.4 Key Manufacturers Flunixin Meglumine API Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Flunixin Meglumine API Product Location Distribution
        3.4.2 Players Flunixin Meglumine API Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Flunixin Meglumine API by Geographic Region
    4.1 World Historic Flunixin Meglumine API Market Size by Geographic Region (2020-2025)
        4.1.1 Global Flunixin Meglumine API Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Flunixin Meglumine API Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Flunixin Meglumine API Market Size by Country/Region (2020-2025)
        4.2.1 Global Flunixin Meglumine API Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Flunixin Meglumine API Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Flunixin Meglumine API Sales Growth
    4.4 APAC Flunixin Meglumine API Sales Growth
    4.5 Europe Flunixin Meglumine API Sales Growth
    4.6 Middle East & Africa Flunixin Meglumine API Sales Growth

5 Americas
    5.1 Americas Flunixin Meglumine API Sales by Country
        5.1.1 Americas Flunixin Meglumine API Sales by Country (2020-2025)
        5.1.2 Americas Flunixin Meglumine API Revenue by Country (2020-2025)
    5.2 Americas Flunixin Meglumine API Sales by Type (2020-2025)
    5.3 Americas Flunixin Meglumine API Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Flunixin Meglumine API Sales by Region
        6.1.1 APAC Flunixin Meglumine API Sales by Region (2020-2025)
        6.1.2 APAC Flunixin Meglumine API Revenue by Region (2020-2025)
    6.2 APAC Flunixin Meglumine API Sales by Type (2020-2025)
    6.3 APAC Flunixin Meglumine API Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Flunixin Meglumine API by Country
        7.1.1 Europe Flunixin Meglumine API Sales by Country (2020-2025)
        7.1.2 Europe Flunixin Meglumine API Revenue by Country (2020-2025)
    7.2 Europe Flunixin Meglumine API Sales by Type (2020-2025)
    7.3 Europe Flunixin Meglumine API Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Flunixin Meglumine API by Country
        8.1.1 Middle East & Africa Flunixin Meglumine API Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Flunixin Meglumine API Revenue by Country (2020-2025)
    8.2 Middle East & Africa Flunixin Meglumine API Sales by Type (2020-2025)
    8.3 Middle East & Africa Flunixin Meglumine API Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Flunixin Meglumine API
    10.3 Manufacturing Process Analysis of Flunixin Meglumine API
    10.4 Industry Chain Structure of Flunixin Meglumine API

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Flunixin Meglumine API Distributors
    11.3 Flunixin Meglumine API Customer

12 World Forecast Review for Flunixin Meglumine API by Geographic Region
    12.1 Global Flunixin Meglumine API Market Size Forecast by Region
        12.1.1 Global Flunixin Meglumine API Forecast by Region (2026-2031)
        12.1.2 Global Flunixin Meglumine API Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Flunixin Meglumine API Forecast by Type (2026-2031)
    12.7 Global Flunixin Meglumine API Forecast by Application (2026-2031)

13 Key Players Analysis
13.1 Rochem International Inc
13.1.1 Rochem International Inc Company Information
13.1.2 Rochem International Inc Flunixin Meglumine API Product Portfolios and Specifications
13.1.3 Rochem International Inc Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Rochem International Inc Main Business Overview
13.1.5 Rochem International Inc Latest Developments
13.2 Ashland
13.2.1 Ashland Company Information
13.2.2 Ashland Flunixin Meglumine API Product Portfolios and Specifications
13.2.3 Ashland Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ashland Main Business Overview
13.2.5 Ashland Latest Developments
13.3 Excella GmbH
13.3.1 Excella GmbH Company Information
13.3.2 Excella GmbH Flunixin Meglumine API Product Portfolios and Specifications
13.3.3 Excella GmbH Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Excella GmbH Main Business Overview
13.3.5 Excella GmbH Latest Developments
13.4 Cayman Chemical
13.4.1 Cayman Chemical Company Information
13.4.2 Cayman Chemical Flunixin Meglumine API Product Portfolios and Specifications
13.4.3 Cayman Chemical Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cayman Chemical Main Business Overview
13.4.5 Cayman Chemical Latest Developments
13.5 NGL Fine-Chem Ltd
13.5.1 NGL Fine-Chem Ltd Company Information
13.5.2 NGL Fine-Chem Ltd Flunixin Meglumine API Product Portfolios and Specifications
13.5.3 NGL Fine-Chem Ltd Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 NGL Fine-Chem Ltd Main Business Overview
13.5.5 NGL Fine-Chem Ltd Latest Developments
13.6 Chemwill Asia Co., Ltd.
13.6.1 Chemwill Asia Co., Ltd. Company Information
13.6.2 Chemwill Asia Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.6.3 Chemwill Asia Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chemwill Asia Co., Ltd. Main Business Overview
13.6.5 Chemwill Asia Co., Ltd. Latest Developments
13.7 Zhejiang Hisoar Pharmaceutical
13.7.1 Zhejiang Hisoar Pharmaceutical Company Information
13.7.2 Zhejiang Hisoar Pharmaceutical Flunixin Meglumine API Product Portfolios and Specifications
13.7.3 Zhejiang Hisoar Pharmaceutical Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zhejiang Hisoar Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hisoar Pharmaceutical Latest Developments
13.8 Shandong Lukang Pharmaceutical Co., Ltd.
13.8.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
13.8.2 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.8.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shandong Lukang Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments
13.9 Hubei Longxiang Pharmaceutical Technology Co., Ltd.
13.9.1 Hubei Longxiang Pharmaceutical Technology Co., Ltd. Company Information
13.9.2 Hubei Longxiang Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.9.3 Hubei Longxiang Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hubei Longxiang Pharmaceutical Technology Co., Ltd. Main Business Overview
13.9.5 Hubei Longxiang Pharmaceutical Technology Co., Ltd. Latest Developments
13.10 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd.
13.10.1 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Company Information
13.10.2 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.10.3 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Main Business Overview
13.10.5 Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Latest Developments
13.11 Shanghai Maclean Biochemical Technology Co., Ltd.
13.11.1 Shanghai Maclean Biochemical Technology Co., Ltd. Company Information
13.11.2 Shanghai Maclean Biochemical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.11.3 Shanghai Maclean Biochemical Technology Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shanghai Maclean Biochemical Technology Co., Ltd. Main Business Overview
13.11.5 Shanghai Maclean Biochemical Technology Co., Ltd. Latest Developments
13.12 Hangzhou Dayangchem
13.12.1 Hangzhou Dayangchem Company Information
13.12.2 Hangzhou Dayangchem Flunixin Meglumine API Product Portfolios and Specifications
13.12.3 Hangzhou Dayangchem Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hangzhou Dayangchem Main Business Overview
13.12.5 Hangzhou Dayangchem Latest Developments
13.13 Qilu Synva Pharmaceutical Co., Ltd.
13.13.1 Qilu Synva Pharmaceutical Co., Ltd. Company Information
13.13.2 Qilu Synva Pharmaceutical Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
13.13.3 Qilu Synva Pharmaceutical Co., Ltd. Flunixin Meglumine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Qilu Synva Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Qilu Synva Pharmaceutical Co., Ltd. Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Flunixin Meglumine API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Flunixin Meglumine API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Solid
 Table 4. Major Players of Liquid
 Table 5. Global Flunixin Meglumine API Sales by Type (2020-2025) & (Kiloton)
 Table 6. Global Flunixin Meglumine API Sales Market Share by Type (2020-2025)
 Table 7. Global Flunixin Meglumine API Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Flunixin Meglumine API Revenue Market Share by Type (2020-2025)
 Table 9. Global Flunixin Meglumine API Sale Price by Type (2020-2025) & (US$/Ton)
 Table 10. Global Flunixin Meglumine API Sale by Application (2020-2025) & (Kiloton)
 Table 11. Global Flunixin Meglumine API Sale Market Share by Application (2020-2025)
 Table 12. Global Flunixin Meglumine API Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Flunixin Meglumine API Revenue Market Share by Application (2020-2025)
 Table 14. Global Flunixin Meglumine API Sale Price by Application (2020-2025) & (US$/Ton)
 Table 15. Global Flunixin Meglumine API Sales by Company (2020-2025) & (Kiloton)
 Table 16. Global Flunixin Meglumine API Sales Market Share by Company (2020-2025)
 Table 17. Global Flunixin Meglumine API Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Flunixin Meglumine API Revenue Market Share by Company (2020-2025)
 Table 19. Global Flunixin Meglumine API Sale Price by Company (2020-2025) & (US$/Ton)
 Table 20. Key Manufacturers Flunixin Meglumine API Producing Area Distribution and Sales Area
 Table 21. Players Flunixin Meglumine API Products Offered
 Table 22. Flunixin Meglumine API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Flunixin Meglumine API Sales by Geographic Region (2020-2025) & (Kiloton)
 Table 26. Global Flunixin Meglumine API Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Flunixin Meglumine API Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Flunixin Meglumine API Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Flunixin Meglumine API Sales by Country/Region (2020-2025) & (Kiloton)
 Table 30. Global Flunixin Meglumine API Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Flunixin Meglumine API Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Flunixin Meglumine API Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Flunixin Meglumine API Sales by Country (2020-2025) & (Kiloton)
 Table 34. Americas Flunixin Meglumine API Sales Market Share by Country (2020-2025)
 Table 35. Americas Flunixin Meglumine API Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Flunixin Meglumine API Sales by Type (2020-2025) & (Kiloton)
 Table 37. Americas Flunixin Meglumine API Sales by Application (2020-2025) & (Kiloton)
 Table 38. APAC Flunixin Meglumine API Sales by Region (2020-2025) & (Kiloton)
 Table 39. APAC Flunixin Meglumine API Sales Market Share by Region (2020-2025)
 Table 40. APAC Flunixin Meglumine API Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Flunixin Meglumine API Sales by Type (2020-2025) & (Kiloton)
 Table 42. APAC Flunixin Meglumine API Sales by Application (2020-2025) & (Kiloton)
 Table 43. Europe Flunixin Meglumine API Sales by Country (2020-2025) & (Kiloton)
 Table 44. Europe Flunixin Meglumine API Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Flunixin Meglumine API Sales by Type (2020-2025) & (Kiloton)
 Table 46. Europe Flunixin Meglumine API Sales by Application (2020-2025) & (Kiloton)
 Table 47. Middle East & Africa Flunixin Meglumine API Sales by Country (2020-2025) & (Kiloton)
 Table 48. Middle East & Africa Flunixin Meglumine API Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Flunixin Meglumine API Sales by Type (2020-2025) & (Kiloton)
 Table 50. Middle East & Africa Flunixin Meglumine API Sales by Application (2020-2025) & (Kiloton)
 Table 51. Key Market Drivers & Growth Opportunities of Flunixin Meglumine API
 Table 52. Key Market Challenges & Risks of Flunixin Meglumine API
 Table 53. Key Industry Trends of Flunixin Meglumine API
 Table 54. Flunixin Meglumine API Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Flunixin Meglumine API Distributors List
 Table 57. Flunixin Meglumine API Customer List
 Table 58. Global Flunixin Meglumine API Sales Forecast by Region (2026-2031) & (Kiloton)
 Table 59. Global Flunixin Meglumine API Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Flunixin Meglumine API Sales Forecast by Country (2026-2031) & (Kiloton)
 Table 61. Americas Flunixin Meglumine API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Flunixin Meglumine API Sales Forecast by Region (2026-2031) & (Kiloton)
 Table 63. APAC Flunixin Meglumine API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Flunixin Meglumine API Sales Forecast by Country (2026-2031) & (Kiloton)
 Table 65. Europe Flunixin Meglumine API Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Flunixin Meglumine API Sales Forecast by Country (2026-2031) & (Kiloton)
 Table 67. Middle East & Africa Flunixin Meglumine API Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Flunixin Meglumine API Sales Forecast by Type (2026-2031) & (Kiloton)
 Table 69. Global Flunixin Meglumine API Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Flunixin Meglumine API Sales Forecast by Application (2026-2031) & (Kiloton)
 Table 71. Global Flunixin Meglumine API Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Rochem International Inc Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 73. Rochem International Inc Flunixin Meglumine API Product Portfolios and Specifications
 Table 74. Rochem International Inc Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Rochem International Inc Main Business
 Table 76. Rochem International Inc Latest Developments
 Table 77. Ashland Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 78. Ashland Flunixin Meglumine API Product Portfolios and Specifications
 Table 79. Ashland Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 80. Ashland Main Business
 Table 81. Ashland Latest Developments
 Table 82. Excella GmbH Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 83. Excella GmbH Flunixin Meglumine API Product Portfolios and Specifications
 Table 84. Excella GmbH Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 85. Excella GmbH Main Business
 Table 86. Excella GmbH Latest Developments
 Table 87. Cayman Chemical Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 88. Cayman Chemical Flunixin Meglumine API Product Portfolios and Specifications
 Table 89. Cayman Chemical Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Cayman Chemical Main Business
 Table 91. Cayman Chemical Latest Developments
 Table 92. NGL Fine-Chem Ltd Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 93. NGL Fine-Chem Ltd Flunixin Meglumine API Product Portfolios and Specifications
 Table 94. NGL Fine-Chem Ltd Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 95. NGL Fine-Chem Ltd Main Business
 Table 96. NGL Fine-Chem Ltd Latest Developments
 Table 97. Chemwill Asia Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 98. Chemwill Asia Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 99. Chemwill Asia Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 100. Chemwill Asia Co., Ltd. Main Business
 Table 101. Chemwill Asia Co., Ltd. Latest Developments
 Table 102. Zhejiang Hisoar Pharmaceutical Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 103. Zhejiang Hisoar Pharmaceutical Flunixin Meglumine API Product Portfolios and Specifications
 Table 104. Zhejiang Hisoar Pharmaceutical Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 105. Zhejiang Hisoar Pharmaceutical Main Business
 Table 106. Zhejiang Hisoar Pharmaceutical Latest Developments
 Table 107. Shandong Lukang Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 108. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 109. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 110. Shandong Lukang Pharmaceutical Co., Ltd. Main Business
 Table 111. Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments
 Table 112. Hubei Longxiang Pharmaceutical Technology Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 113. Hubei Longxiang Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 114. Hubei Longxiang Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 115. Hubei Longxiang Pharmaceutical Technology Co., Ltd. Main Business
 Table 116. Hubei Longxiang Pharmaceutical Technology Co., Ltd. Latest Developments
 Table 117. Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 118. Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 119. Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 120. Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Main Business
 Table 121. Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd. Latest Developments
 Table 122. Shanghai Maclean Biochemical Technology Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 123. Shanghai Maclean Biochemical Technology Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 124. Shanghai Maclean Biochemical Technology Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 125. Shanghai Maclean Biochemical Technology Co., Ltd. Main Business
 Table 126. Shanghai Maclean Biochemical Technology Co., Ltd. Latest Developments
 Table 127. Hangzhou Dayangchem Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 128. Hangzhou Dayangchem Flunixin Meglumine API Product Portfolios and Specifications
 Table 129. Hangzhou Dayangchem Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 130. Hangzhou Dayangchem Main Business
 Table 131. Hangzhou Dayangchem Latest Developments
 Table 132. Qilu Synva Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine API Manufacturing Base, Sales Area and Its Competitors
 Table 133. Qilu Synva Pharmaceutical Co., Ltd. Flunixin Meglumine API Product Portfolios and Specifications
 Table 134. Qilu Synva Pharmaceutical Co., Ltd. Flunixin Meglumine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 135. Qilu Synva Pharmaceutical Co., Ltd. Main Business
 Table 136. Qilu Synva Pharmaceutical Co., Ltd. Latest Developments


List of Figures
 Figure 1. Picture of Flunixin Meglumine API
 Figure 2. Flunixin Meglumine API Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Flunixin Meglumine API Sales Growth Rate 2020-2031 (Kiloton)
 Figure 7. Global Flunixin Meglumine API Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Flunixin Meglumine API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Flunixin Meglumine API Sales Market Share by Country/Region (2024)
 Figure 10. Flunixin Meglumine API Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Solid
 Figure 12. Product Picture of Liquid
 Figure 13. Global Flunixin Meglumine API Sales Market Share by Type in 2025
 Figure 14. Global Flunixin Meglumine API Revenue Market Share by Type (2020-2025)
 Figure 15. Flunixin Meglumine API Consumed in Horse
 Figure 16. Global Flunixin Meglumine API Market: Horse (2020-2025) & (Kiloton)
 Figure 17. Flunixin Meglumine API Consumed in Pig
 Figure 18. Global Flunixin Meglumine API Market: Pig (2020-2025) & (Kiloton)
 Figure 19. Flunixin Meglumine API Consumed in Cattle
 Figure 20. Global Flunixin Meglumine API Market: Cattle (2020-2025) & (Kiloton)
 Figure 21. Flunixin Meglumine API Consumed in Others
 Figure 22. Global Flunixin Meglumine API Market: Others (2020-2025) & (Kiloton)
 Figure 23. Global Flunixin Meglumine API Sale Market Share by Application (2024)
 Figure 24. Global Flunixin Meglumine API Revenue Market Share by Application in 2025
 Figure 25. Flunixin Meglumine API Sales by Company in 2025 (Kiloton)
 Figure 26. Global Flunixin Meglumine API Sales Market Share by Company in 2025
 Figure 27. Flunixin Meglumine API Revenue by Company in 2025 ($ millions)
 Figure 28. Global Flunixin Meglumine API Revenue Market Share by Company in 2025
 Figure 29. Global Flunixin Meglumine API Sales Market Share by Geographic Region (2020-2025)
 Figure 30. Global Flunixin Meglumine API Revenue Market Share by Geographic Region in 2025
 Figure 31. Americas Flunixin Meglumine API Sales 2020-2025 (Kiloton)
 Figure 32. Americas Flunixin Meglumine API Revenue 2020-2025 ($ millions)
 Figure 33. APAC Flunixin Meglumine API Sales 2020-2025 (Kiloton)
 Figure 34. APAC Flunixin Meglumine API Revenue 2020-2025 ($ millions)
 Figure 35. Europe Flunixin Meglumine API Sales 2020-2025 (Kiloton)
 Figure 36. Europe Flunixin Meglumine API Revenue 2020-2025 ($ millions)
 Figure 37. Middle East & Africa Flunixin Meglumine API Sales 2020-2025 (Kiloton)
 Figure 38. Middle East & Africa Flunixin Meglumine API Revenue 2020-2025 ($ millions)
 Figure 39. Americas Flunixin Meglumine API Sales Market Share by Country in 2025
 Figure 40. Americas Flunixin Meglumine API Revenue Market Share by Country (2020-2025)
 Figure 41. Americas Flunixin Meglumine API Sales Market Share by Type (2020-2025)
 Figure 42. Americas Flunixin Meglumine API Sales Market Share by Application (2020-2025)
 Figure 43. United States Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 44. Canada Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 45. Mexico Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 46. Brazil Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 47. APAC Flunixin Meglumine API Sales Market Share by Region in 2025
 Figure 48. APAC Flunixin Meglumine API Revenue Market Share by Region (2020-2025)
 Figure 49. APAC Flunixin Meglumine API Sales Market Share by Type (2020-2025)
 Figure 50. APAC Flunixin Meglumine API Sales Market Share by Application (2020-2025)
 Figure 51. China Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 52. Japan Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 53. South Korea Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 54. Southeast Asia Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 55. India Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 56. Australia Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 57. China Taiwan Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 58. Europe Flunixin Meglumine API Sales Market Share by Country in 2025
 Figure 59. Europe Flunixin Meglumine API Revenue Market Share by Country (2020-2025)
 Figure 60. Europe Flunixin Meglumine API Sales Market Share by Type (2020-2025)
 Figure 61. Europe Flunixin Meglumine API Sales Market Share by Application (2020-2025)
 Figure 62. Germany Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 63. France Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 64. UK Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 65. Italy Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 66. Russia Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 67. Middle East & Africa Flunixin Meglumine API Sales Market Share by Country (2020-2025)
 Figure 68. Middle East & Africa Flunixin Meglumine API Sales Market Share by Type (2020-2025)
 Figure 69. Middle East & Africa Flunixin Meglumine API Sales Market Share by Application (2020-2025)
 Figure 70. Egypt Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 71. South Africa Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 72. Israel Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 73. Turkey Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 74. GCC Countries Flunixin Meglumine API Revenue Growth 2020-2025 ($ millions)
 Figure 75. Manufacturing Cost Structure Analysis of Flunixin Meglumine API in 2025
 Figure 76. Manufacturing Process Analysis of Flunixin Meglumine API
 Figure 77. Industry Chain Structure of Flunixin Meglumine API
 Figure 78. Channels of Distribution
 Figure 79. Global Flunixin Meglumine API Sales Market Forecast by Region (2026-2031)
 Figure 80. Global Flunixin Meglumine API Revenue Market Share Forecast by Region (2026-2031)
 Figure 81. Global Flunixin Meglumine API Sales Market Share Forecast by Type (2026-2031)
 Figure 82. Global Flunixin Meglumine API Revenue Market Share Forecast by Type (2026-2031)
 Figure 83. Global Flunixin Meglumine API Sales Market Share Forecast by Application (2026-2031)
 Figure 84. Global Flunixin Meglumine API Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Rochem International Inc

Ashland

Excella GmbH

Cayman Chemical

NGL Fine-Chem Ltd

Chemwill Asia Co., Ltd.

Zhejiang Hisoar Pharmaceutical

Shandong Lukang Pharmaceutical Co., Ltd.

Hubei Longxiang Pharmaceutical Technology Co., Ltd.

Beijing Xiangyu Hengtian Pharmaceutical Technology Co., Ltd.

Shanghai Maclean Biochemical Technology Co., Ltd.

Hangzhou Dayangchem

Qilu Synva Pharmaceutical Co., Ltd.

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff